| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACC.2008.09.019 |
| P698 | PubMed publication ID | 19095136 |
| P50 | author | Dudley Pennell | Q42778112 |
| P2093 | author name string | Srijita Sen-Chowdhry | |
| William J McKenna | |||
| Sanjay K Prasad | |||
| Petros Syrris | |||
| Siân E Hughes | |||
| Deirdre Ward | |||
| Robert Merrifield | |||
| P433 | issue | 25 | |
| P921 | main subject | cardiomyopathy | Q847583 |
| P304 | page(s) | 2175-2187 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity | |
| P478 | volume | 52 |
| Q90017963 | A case report of arrhythmogenic ventricular cardiomyopathy presenting with sustained ventricular tachycardia arising from the right and the left ventricles before structural changes are documented |
| Q28250468 | A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy |
| Q38816327 | A meta-analysis for echocardiographic assessment of right ventricular structure and function in ARVC |
| Q58128759 | A novel desmin mutation causing severe left ventricular arrhythmogenic cardiomyopathy/dysplasia |
| Q82962303 | A novel variant in plakophilin-2 gene detected in a family with arrhythmogenic right ventricular cardiomyopathy |
| Q92759012 | ACTN2 variant associated with a cardiac phenotype suggestive of left-dominant arrhythmogenic cardiomyopathy |
| Q96233952 | An unusual cause of ventricular fibrillatory arrest |
| Q53561111 | Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. |
| Q33167672 | Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes |
| Q88311055 | Arrhythmogenic Cardiomyopathy: Mechanotransduction Going Wrong |
| Q92740412 | Arrhythmogenic Left Ventricular Cardiomyopathy: A Clinical and CMR Study |
| Q33166353 | Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias. |
| Q90734431 | Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management |
| Q89958699 | Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy |
| Q36651104 | Arrhythmogenic Right Ventricular Cardiomyopathy: Electroarchitecture of the Substrate |
| Q38826183 | Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy. |
| Q26753099 | Arrhythmogenic cardiomyopathy |
| Q93137622 | Arrhythmogenic cardiomyopathy with left ventricular involvement versus ischemic heart disease: lessons learned from the family study and the reviewed autopsy of a young male |
| Q33906065 | Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management |
| Q90577852 | Arrhythmogenic left ventricular cardiomyopathy |
| Q34465268 | Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update |
| Q55186296 | Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: the diagnosis as a link to the human disease. |
| Q84905617 | Arrhythmogenic right ventricular cardiomyopathy. What is needed for a cure? |
| Q30489889 | Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study |
| Q34780116 | Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges |
| Q95729750 | Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis |
| Q37994613 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature |
| Q35607769 | Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy. |
| Q87493446 | Arrhythmogenic ventricular cardiomyopathy and sudden cardiac death: Left or right? |
| Q27024037 | Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease |
| Q60922442 | Arrythmogenic Right Ventricular Cardiomiopathy/Dysplasia (ARVC/D) - What We Have Learned after 40 Years of the Diagnosis of This Clinical Entity |
| Q99619173 | Athlete's heart and other entities to consider around |
| Q58716506 | Cardiac Magnetic Resonance Imaging (MRI) Findings in Arrhythmogenic Right Ventricular Dysplasia (ARVD) Compared with Echocardiography |
| Q30558233 | Cardiac imaging techniques for physicians: late enhancement |
| Q46990439 | Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist? |
| Q90435028 | Cardiomyopathies |
| Q37848215 | Cardiovascular magnetic resonance in heart failure |
| Q41451219 | Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2. |
| Q38662414 | Cell models of arrhythmogenic cardiomyopathy: advances and opportunities |
| Q98894474 | Clinical Presentation, Cardiac Magnetic Resonance Findings, and Prognosis of Patients with Arrhythmogenic Right Ventricular Cardiomyopathy - An Experience from Pakistan |
| Q35054950 | Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals |
| Q35488614 | Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. |
| Q37349517 | Clinical usefulness of immunohistochemistry for plakoglobin, N-cadherin, and connexin-43 in the diagnosis of arrhythmogenic right ventricular cardiomyopathy |
| Q99613010 | Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q62476511 | Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology |
| Q39030731 | Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging |
| Q37572134 | Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model |
| Q90613298 | Desmoplakin Variant-Associated Arrhythmogenic Cardiomyopathy Presenting as Acute Myocarditis |
| Q33764619 | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria |
| Q55638651 | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. |
| Q30463822 | Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies |
| Q88454366 | Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient |
| Q87396216 | Dilated cardiomyopathy |
| Q91899324 | Dilated cardiomyopathy |
| Q39283141 | Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing |
| Q89441783 | Epsilon waves: Milestones in the discovery and progress |
| Q50167027 | Evolving concepts in dilated cardiomyopathy. |
| Q94478119 | Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies |
| Q92132136 | Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue |
| Q90082106 | Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy |
| Q39270856 | Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy |
| Q38107893 | Genetic evaluation of dilated cardiomyopathy |
| Q38058475 | Genetic testing in the contemporary diagnosis of cardiomyopathy |
| Q91799093 | High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia |
| Q38211720 | How to recognize epicardial origin of ventricular tachycardias? |
| Q41892305 | Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. |
| Q30473247 | Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy |
| Q58577361 | Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation |
| Q41485480 | Incessant left ventricular tachycardia of unusual etiology |
| Q48501295 | Inherited cardiomyopathies and sports participation |
| Q55317616 | Isolated, premature ventricular complex-induced right ventricular dysfunction mimicking arrhythmogenic right ventricular cardiomyopathy. |
| Q35171347 | Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy - a cardiac magnetic resonance imaging study |
| Q42404059 | Left-dominant Arrhythmogenic Cardiomyopathy: A Case Misdiagnosed as Pseudoaneurysm |
| Q96768170 | Left-dominant arrhythmogenic cardiomyopathy with a nonsense mutation in DSP |
| Q92877503 | Letter by Pérez-Riera et al Regarding Article, "Left-Dominant Arrhythmogenic Cardiomyopathy With Heterozygous Mutations in DSP and MYBPC3" |
| Q34903406 | MR and CT imaging of Arrhythmogenic Cardiomyopathy |
| Q38887628 | Management of survivors of cardiac arrest - the importance of genetic investigation |
| Q42805646 | MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy |
| Q91524160 | Minimal inflammatory foci of unknown etiology may be a tentative sign of early stage inherited cardiomyopathy |
| Q83299496 | Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells |
| Q91557750 | Molecular mechanisms of arrhythmogenic cardiomyopathy |
| Q92010580 | Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant |
| Q37433690 | Mutation analysis of the candidate genes SCN1B-4B, FHL1, and LMNA in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q82429955 | Myocardial Fat at Cardiac Imaging: How Can We Differentiate Pathologic from Physiologic Fatty Infiltration? |
| Q57654519 | Myocardial fat overgrowth in Proteus syndrome |
| Q37292752 | Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy |
| Q90632760 | Natural History of Arrhythmogenic Cardiomyopathy |
| Q41776920 | Nature and Nurture in Arrhythmogenic Right Ventricular Cardiomyopathy - A Clinical Perspective |
| Q36706648 | Next generation sequencing-based copy number analysis reveals low prevalence of deletions and duplications in 46 genes associated with genetic cardiomyopathies |
| Q63729245 | Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart |
| Q37116397 | Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes |
| Q64056904 | Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement |
| Q47131063 | Novel gene mutation identified in a patient with arrhythmogenic ventricular cardiomyopathy |
| Q64115173 | Optimizing RV lead position in RV cardiomyopathy: Are we there yet? |
| Q38846518 | Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease |
| Q37962327 | Pathophysiology of arrhythmogenic cardiomyopathy |
| Q92718026 | Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation |
| Q28253770 | Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers |
| Q36330386 | Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy |
| Q37058496 | Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population |
| Q92612178 | Position Statement on Indications of Echocardiography in Adults - 2019 |
| Q37721775 | Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia. |
| Q90082110 | Predicting Arrhythmia Risk in Dilated Cardiomyopathy Using Genetic Mutation Status |
| Q34562331 | Prevalence of left ventricular regional dysfunction in arrhythmogenic right ventricular dysplasia: a tagged MRI study |
| Q90668307 | Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy |
| Q36716425 | Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy |
| Q28246772 | Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy |
| Q88873897 | Right bundle branch block and conduction disturbances in Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy |
| Q38201068 | Science and practice of arrhythmogenic cardiomyopathy: A paradigm shift |
| Q91609934 | Screening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias |
| Q64230001 | Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy |
| Q38191069 | Sudden cardiac death in patients with nonischemic cardiomyopathy |
| Q43095707 | Sustained ventricular tachycardia in an apparently healthy heart: a very localized left dominant arrhythmogenic cardiomyopathy |
| Q28256845 | The ARVD/C genetic variants database: 2014 update |
| Q37809077 | The Pathobiology of Arrhythmogenic Cardiomyopathy |
| Q43962585 | The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing |
| Q40954073 | The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy |
| Q27692617 | The pre-participation examination for leisure time physical activity: general medical and cardiological issues |
| Q34439332 | The role of cardiac magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular dysplasia |
| Q34679867 | The role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers. |
| Q42957210 | Tissue-resident Sca1+ PDGFRα+ mesenchymal progenitors are the cellular source of fibrofatty infiltration in arrhythmogenic cardiomyopathy |
| Q26799143 | Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement |
| Q26799094 | Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement |
| Q41446453 | Unique Association of Rare Cardiovascular Disease in an Athlete With Ventricular Arrhythmias |
| Q39398133 | Using genetic testing to guide therapeutic decisions in cardiomyopathy |
| Q89052557 | Ventricular Arrhythmias in Young Competitive Athletes: Prevalence, Determinants, and Underlying Substrate |
| Q53303061 | [Update on cardiac imaging techniques: echocardiography, cardiac magnetic resonance and computed tomography]. |
Search more.